Drugs / Monovalent Subvirion A/H1N1 influenza vaccine with adjuvant
Monovalent Subvirion A/H1N1 influenza vaccine with adjuvant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00952276 | Oct 2009 → Dec 2010 | swine influenza | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent Subvirion A/H1N1 influenza vaccine with adjuvant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00952276 ↗ |
| Modality | Vaccine | “candidate vaccines” NCT00952276 ↗ |
| Route | Intramuscular | “Intramuscular on Day 0” NCT00952276 ↗ |